Bankruptcy's global onslaught

From VC to licensing, Exelixis has done every kind of deal to keep itself afloat, except one. Is an acquisition next?

As Dubai's decade-long, debt-funded spending spree comes to an end, sheikhs must rescue each other.

Inbound private equity in China is down, but prices have fallen and prospects look up. Go figure.

A conversation about healthcare with Hamilton Moses III.

Old ones get restructured. New ones help companies play defense.

As companies reach out for financing, banks are quick to revise terms on a popular credit vehicle.

Amid widening dismay over the bailouts, there is a continuing chorus of economists calling for full nationalization of failing financial institutions.

The $19 billion healthcare stimulus plan helps create a rising tide, but will it buoy technology companies?

As some private equity players are drawn to distressed debt plays, LPs worry about the expertise and conflicts.

With newspapers going bankrupt and shuttering operations, we get to see how they cover their own demise -- or don't.

Don't call them vultures, But some media execs are waiting for companies to fall into their laps.

Terra Firma's Guy Hands looks to keep his LPs happy. But what happens when the recession deepens?

Syndicated credit facility debt -- a new investment opportunity for private equity firms.

Leo Strine allows AIG shareholders to sue Hank Greenberg and his underlings but lets PricewaterhouseCoopers off the hook.

Start by putting Rick Santelli in charge of the silent majority.

The duties of directors of distressed companies.

New foreign investment laws and their impact on acquiring Russian companies.

Accounting standards setters drop 'determined' effort but reach a reasonable solution.

Merrill's Andrea Orcel took home $33.8M in 2008, says the Journal.

HBS' Josh Lerner: A VC-backed entrepreneur who succeeded once has a 30% chance to do so again.

John DeQ Briggs is leaving Howrey for AV&H to help build out its antitrust practice.

Liberty turned to Marc Leaf and Martin Toulouse at longtime counsel Baker Botts on its XM Sirius investment.

Fenderstock, now CEO of Broadpoint Securities, will take the helm at the new Broadpoint Gleacher. '80s merger maven Gleacher will be chairman.

Skadden Arps' Brian Duwe and Richard Witzel Jr. are advising hunter-turned-prey CF Industries.

Oslers' John Macfarlane was one of Nova's many advisers on its $2.3 billion sale to Ipic.

Latham's Alan Mendelson is advising CVT as it fields Astellas' $1 billion offer.

March 9, 12 and 20 are important days in the M&A world.

As the crisis advances, the debate over what to do gets noisier, crazier and more extreme. Makes you wonder if we're making any progress at all.